Guidelines
Concise reminders for common RADS systems, incidental findings and imaging safety. Always match the official source and local policy.
Incidental lung nodule on non-screening CT.
Low-dose CT lung cancer screening report.
Cirrhosis/chronic HBV or eligible HCC-risk population.
Routine HCC surveillance ultrasound.
Thyroid ultrasound with one or more nodules.
Any breast imaging report.
Adnexal lesion on pelvic ultrasound.
Indeterminate adnexal lesion undergoing MRI.
Unexpected finding not related to the indication.
Adrenal lesion found incidentally on CT/MRI.
Renal lesion detected on CT/MRI/US.
Complex cystic renal mass.
Unexpected liver lesion on CT/US/MRI.
Incidental pancreatic cystic lesion.
Unexpected splenic lesion.
Unexpected gallbladder or biliary abnormality.
Incidental adnexal lesion on CT/MRI/US.
Pineal cyst found incidentally.
Targeted or survey breast ultrasound report.
Before contrast-enhanced CT/MRI in patient with prior reaction.
Before iodinated contrast or selected gadolinium exams.
Pregnant patient needing diagnostic imaging.
Before any MRI exam.
Multiparametric prostate MRI for detection, localization and staging support.
Post-treatment head and neck CT/MRI/PET reporting.
Screening or diagnostic CT colonography reports.
Coronary CTA reports for CAD assessment.
Local staging of bladder cancer on multiparametric MRI.
Unexpected solitary bone lesion in adults.
MSK tumor imaging and follow-up communication.
Soft tissue tumor MRI/US/CT structured communication.
Glioma or treated brain tumor follow-up MRI.
Traumatic brain injury CT/MRI reporting.
Thyroid nodule ultrasound terminology and teaching.
Incidental thyroid nodule on neck/chest imaging.
Unexpected nodal enlargement without known target disease.
Unexpected vascular abnormality on CT/MRI.
Unexpected uterine finding on CT/MRI/US.
Incidental prostate abnormality on CT/MRI.
Incidental scrotal lesion on US/CT/MRI.
Unexpected parathyroid-region lesion.
Incidental sellar/pituitary abnormality.
Unexpected hepatic steatosis on imaging.
CT pulmonary angiography report.
HRCT chest for suspected ILD.
CT/MRI chest with mediastinal mass.
CT/US chest pleural abnormality.
Dynamic contrast-enhanced breast MRI.
Screening/diagnostic mammography.
Image-guided breast biopsy reporting.
Post-ablation/TACE/Y90 liver MRI/CT in eligible HCC-risk patients.
CT/MRI pancreatitis assessment.
CT/MR enterography for IBD.
Primary/restaging rectal cancer MRI.
Prostate mpMRI.
Acute stroke imaging pathway.
Brain MRI for metastasis staging/follow-up.
MRI brain/spine for demyelination.
Pituitary MRI.
Any contrast administration area.
Iodinated or gadolinium contrast injection complication.
Contrast CT in patient taking metformin.
MRI contrast in renal impairment.
Pregnant or breastfeeding patient requiring MRI contrast.
Breastfeeding patient receiving contrast.
Pediatric CT/MRI contrast exam.
Contrast-enhanced ultrasound.
Any pediatric ionizing radiation exam.
Adult CT/fluoroscopy/nuclear medicine imaging.
Ovarian/adnexal cyst on ultrasound.
Thyroid nodule ultrasound.
Early pregnancy ultrasound.
Suspected lower extremity DVT.
Carotid Doppler ultrasound.
Ultrasound elastography for chronic liver disease.
Postmenopausal bleeding ultrasound.
Shoulder pain or suspected cuff tear.
Bone pain with suspected stress fracture.
Suspected osteomyelitis.
Chest CT/MRI with cardiac abnormality.
Cardiomyopathy or ischemic viability MRI.
Child with suspected appendicitis.
Child with UTI or reflux concern.
Infant DDH screening or risk factors.
Biopsy, drainage or vascular intervention planning.
Any percutaneous image-guided biopsy.